DSCAM-AS1 and prostate carcinoma: To characterize the expression of DSCAM-AS1, its expression levels were analyzed in TCGA data, showing it was specifically expressed in breast cancer, lung cancer and prostate cancer but not in adjacent normal tissues (Figure 1D).